Annual CFI
-$3000.00
+$7000.00+70.00%
31 December 2023
Summary:
NRx Pharmaceuticals annual cash flow from investing activities is currently -$3000.00, with the most recent change of +$7000.00 (+70.00%) on 31 December 2023. During the last 3 years, it has fallen by -$1000.00 (-50.00%). NRXPW annual CFI is now -100.01% below its all-time high of $40.25 million, reached on 31 December 2019.NRXPW Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$0.00
$0.000.00%
30 September 2024
Summary:
NRx Pharmaceuticals quarterly cash flow from investing activities is currently $0.00, unchanged on 30 September 2024. Over the past year, it has increased by +$2000.00 (+100.00%). NRXPW quarterly CFI is now -100.00% below its all-time high of $25.93 million, reached on 31 March 2020.NRXPW Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
$1000.00
+$2000.00+200.00%
30 September 2024
Summary:
NRx Pharmaceuticals TTM cash flow from investing activities is currently $1000.00, with the most recent change of +$2000.00 (+200.00%) on 30 September 2024. Over the past year, it has increased by +$3000.00 (+150.00%). NRXPW TTM CFI is now -100.00% below its all-time high of $66.68 million, reached on 31 March 2020.NRXPW TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NRXPW Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +70.0% | +100.0% | +150.0% |
| 3 y3 years | -50.0% | +100.0% | -99.6% |
| 5 y5 years | - | -100.0% | -100.0% |
NRXPW Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -50.0% | +70.0% | -100.0% | +100.0% | -99.6% | +131.0% |
| 5 y | 5 years | -100.0% | +70.0% | -100.0% | +100.0% | -100.0% | +131.0% |
| alltime | all time | -100.0% | +70.0% | -100.0% | +100.0% | -100.0% | +100.2% |
NRx Pharmaceuticals Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $0.00(0.0%) | $1000.00(-200.0%) |
| June 2024 | - | $0.00(0.0%) | -$1000.00(0.0%) |
| Mar 2024 | - | $0.00(-100.0%) | -$1000.00(0.0%) |
| Dec 2023 | -$3000.00(-70.0%) | $1000.00(-150.0%) | -$1000.00(-50.0%) |
| Sept 2023 | - | -$2000.00(-33.3%) | -$2000.00(-37.9%) |
| Dec 2022 | -$10.00 K(+42.9%) | - | - |
| June 2022 | - | -$3000.00(0.0%) | -$3221.22(+1338.0%) |
| Mar 2022 | - | -$3000.00(-145.4%) | -$224.00(-108.1%) |
| Dec 2021 | -$7000.00 | $6607.78(-272.6%) | $2776.00(-99.0%) |
| Sept 2021 | - | -$3829.00(>+9900.0%) | $269.14 K(-1.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2021 | - | -$2.78(<-9900.0%) | $272.97 K(+9.3%) |
| Mar 2021 | - | $0.00(-100.0%) | $249.75 K(-99.0%) |
| Dec 2020 | -$2000.00(-100.0%) | $272.97 K(>+9900.0%) | $26.18 M(-26.4%) |
| Sept 2020 | - | $0.00(-100.0%) | $35.55 M(-20.1%) |
| June 2020 | - | -$23.22 K(-100.1%) | $44.48 M(-33.3%) |
| Mar 2020 | - | $25.93 M(+168.8%) | $66.68 M(+65.7%) |
| Dec 2019 | $40.25 M | $9.64 M(+8.0%) | $40.25 M(+31.5%) |
| Sept 2019 | - | $8.93 M(-59.7%) | $30.60 M(+41.2%) |
| June 2019 | - | $22.18 M(-4464.2%) | $21.67 M(-4364.2%) |
| Mar 2019 | - | -$508.21 K | -$508.21 K |
FAQ
- What is NRx Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals annual CFI year-on-year change?
- What is NRx Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals quarterly CFI year-on-year change?
- What is NRx Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals TTM CFI year-on-year change?
What is NRx Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of NRXPW is -$3000.00
What is the all time high annual CFI for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high annual cash flow from investing activities is $40.25 M
What is NRx Pharmaceuticals annual CFI year-on-year change?
Over the past year, NRXPW annual cash flow from investing activities has changed by +$7000.00 (+70.00%)
What is NRx Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of NRXPW is $0.00
What is the all time high quarterly CFI for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high quarterly cash flow from investing activities is $25.93 M
What is NRx Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, NRXPW quarterly cash flow from investing activities has changed by +$2000.00 (+100.00%)
What is NRx Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of NRXPW is $1000.00
What is the all time high TTM CFI for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high TTM cash flow from investing activities is $66.68 M
What is NRx Pharmaceuticals TTM CFI year-on-year change?
Over the past year, NRXPW TTM cash flow from investing activities has changed by +$3000.00 (+150.00%)